RISK OF THROMBOEMBOLISM IN NON-VALVULAR ATRIAL FIBRILLATION AND ADEQUACY OF ANTICOAGULATION IN HIGH RISK PATIENTS
DOI:
https://doi.org/10.47144/phj.v51i4.1603Abstract
Objective: To assess frequency of non-valvular AF, with high risk ofthromboembolism and their adequacy of anticoagulation.
Methodology: This study was conducted at National Institute of CardiovascularDisease Karachi from 1st May to 30th September 2017, included patients withnon-valvular AF. Patients were stratified according to thromboembolic risk onCHA DS VASc 2 2 score with more than or equal to 2 as high risk. Information aboutdifferent types of anticoagulant medications was obtained along with recent INRlevel. SPSS 19 was used for the analysis of data and t-test, and Chi-square testswere applied for the assessment and comparison of data. Two sided p≤ 0.05was taken as criteria for statistical significance.
Results: A total of 160 patient were studied,52.5% (84) were males, 85.6% (137)found to have CHA DS -VASc score 2 or above. Out of them 62.8% (86) were 2 2taking warfarin and 13.1% (18) were taking Novel oral anticoagulant(NOAC). Outof those at high risk on warfarin only 20.9% (18), were adequatelyanticoagulated.
Conclusion: In our study majority of patients with non-valvular AF were at higherrisk of thromboembolism with inadequate anticoagulation. Strategies to improveanticoagulation are needed in this group.
Key Words: Atrial fibrillation, Anticoagulation, Thromboembolism,Warfarin, Nonvalvular atrial fibrillation
Downloads
Downloads
How to Cite
Issue
Section
License
When an article is accepted for publication in the print format, the author will be required to transfer exclusive copyright to the PHJ and retain the rights to use and share their published article with others. However, re-submission of the full article or any part for publication by a third party would require prior permission of the PHJ.
Online publication will allow the author to retain the copyright and share the article under the agreement described in the licensing rights with creative commons, with appropriate attribution to PHJ. Creative Commons attribution license CC BY 4.0 is applied to articles published in PHJ https://creativecommons.org/licenses/by/4.0/